|
|
|
Volumn 39, Issue 1, 2002, Pages
|
|
Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE;
ALISKIREN;
ANGIOTENSIN I;
ANGIOTENSIN II;
ANTIHYPERTENSIVE AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FUMARIC ACID DERIVATIVE;
POTASSIUM;
RENIN;
SODIUM;
ADULT;
ARTICLE;
BLOOD;
BLOOD PRESSURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG EFFECT;
HEART RATE;
HUMAN;
MALE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
URINE;
ADMINISTRATION, ORAL;
ADULT;
ALDOSTERONE;
ANGIOTENSIN I;
ANGIOTENSIN II;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
ENALAPRIL;
FUMARATES;
HEART RATE;
HUMANS;
MALE;
POTASSIUM;
RENIN;
RENIN-ANGIOTENSIN SYSTEM;
SODIUM;
|
|
EID: 0036372173
PISSN: None
EISSN: 15244563
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (398)
|
|
References (0)
|
